Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
复制标题

DOI:
10.1593/neo.13172
复制
发表时间:
2013-07-01
期刊:
影响因子:
4.8
通讯作者:
Aigner, Achim
Aigner, Achim
中科院分区:
医学2区
文献类型:
--
作者:
Weirauch, Ulrike;Beckmann, Nadine;Aigner, Achim

文献摘要

被引文献

相似文献

目得:莫洛尼鼠白血病病毒1(Pim-1)激酶的前病毒整合位点在各种肿瘤中过表达,并与预后不良有关。其作为原癌基因的作用是基于参与关键细胞过程的几种Pim-1靶蛋白。在这里,我们探讨Pim-1在结肠癌中的功能相关性。实验设计:使用基于RNAi的敲低方法以及特异性小分子抑制剂来抑制结肠癌细胞中的Pim-1。在体外和体内小鼠肿瘤模型中分析了增殖、细胞凋亡、对细胞生长抑制治疗的敏感性和总体抗肿瘤作用。结果:我们证明了Pim-1抑制的抗增殖、促凋亡和总体抗肿瘤作用。Pim-1敲低后对5-氟尿嘧啶(5-FU)治疗的敏感性为组合治疗方法提供了新的可能性。重要的是,这也拮抗了5-FU触发的Pim-1上调,这是由miR-15 b水平降低介导的,miR-15 b是我们新发现的一种调节Pim-1的microRNA。Pim-1抑制的分子效应分析揭示了一个复杂的调控网络,治疗性Pim-1抑制导致致癌信号转导的主要变化,涉及p21(Cip 1/WAF 1)、STAT 3、c-jun-N-末端激酶(JNK)、c-Myc和生存素,以及凋亡相关蛋白Puma、Bax和Bcl-xL的水平。结论:我们证明Pim-1在几个肿瘤相关信号通路中起着关键作用,并建立了Pim-1在结肠癌中的功能相关性。我们的研究结果也证实了基于聚合物聚乙烯亚胺/小干扰RNA纳米颗粒的RNAi介导的Pim-1敲低作为一种有前途的治疗方法。
PURPOSE: The provirus integration site for Moloney murine leukemia virus 1 (Pim-1) kinase is overexpressed in various tumors and has been linked to poor prognosis. Its role as proto-oncogene is based on several Pim-1 target proteins involved in pivotal cellular processes. Here, we explore the functional relevance of Pim-1 in colon carcinoma. EXPERIMENTAL DESIGN: RNAi-based knockdown approaches, as well as a specific small molecule inhibitor, were used to inhibit Pim-1 in colon carcinoma cells. The effects were analyzed regarding proliferation, apoptosis, sensitization toward cytostatic treatment, and overall antitumor effect in vitro and in mouse tumor models in vivo. RESULTS: We demonstrate antiproliferative, proapoptotic, and overall antitumor effects of Pim-1 inhibition. The sensitization to 5-fluorouracil (5-FU) treatment upon Pim-1 knockdown offers new possibilities for combinatorial treatment approaches. Importantly, this also antagonizes a 5-FU-triggered Pim-1 up-regulation, which is mediated by decreased levels of miR-15b, a microRNA we newly identify to regulate Pim-1. The analysis of the molecular effects of Pim-1 inhibition reveals a complex regulatory network, with therapeutic Pim-1 repression leading to major changes in oncogenic signal transduction with regard to p21(Cip1/WAF1), STAT3, c-jun-N-terminal kinase (JNK), c-Myc, and survivin and in the levels of apoptosis-related proteins Puma, Bax, and Bcl-xL. CONCLUSIONS: We demonstrate that Pim-1 plays a pivotal role in several tumor-relevant signaling pathways and establish the functional relevance of Pim-1 in colon carcinoma. Our results also substantiate the RNAi-mediated Pim-1 knockdown based on polymeric polyethylenimine/small interfering RNA nanoparticles as a promising therapeutic approach.